Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 7

AI Proteins and Astellas Sign $400 Million Drug Discovery Deal

Oct 23, 2026
AI Proteins has signed a research collaboration and licensing agreement with Astellas Pharma to discover and develop new miniprotein-based medicines using artificial intelligence (AI).…
Read More...

AstraZeneca Wins FDA Approval for Ultomiris in IgA Nephropathy

Oct 23, 2026
AstraZeneca has received accelerated approval from the US Food and Drug Administration (FDA) for Ultomiris (ravulizumab) to reduce protein levels in the urine of adults with primary…
Read More...

Cosette Pharma Wins FDA Approval for EVOXAC Oral Solution

Oct 23, 2026
Cosette Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for EVOXAC (cevimeline hydrochloride) oral solution to treat symptoms of dry mouth in adults…
Read More...

GSK Wins FDA Approval for Hibsago to Treat Chronic Hepatitis B

Oct 23, 2026
GSK has received approval from the US Food and Drug Administration (FDA) for Hibsago (bepirovirsen), a new treatment for certain adults living with chronic hepatitis B. The approval…
Read More...

EU Approves Keytruda and Padcev for Muscle-Invasive Bladder Cancer

Oct 23, 2026
The European Commission has approved Merck’s Keytruda (pembrolizumab) in combination with Padcev (enfortumab vedotin-ejfv) as a perioperative treatment for adults with resectable…
Read More...

Big Pharma Turns to AI to Find New Drugs

Oct 21, 2026
Big pharma is investing in AI drug discovery through major partnerships with biotech and technology companies, aiming to find new drug targets and develop medicines faster.
Read More...

AbbVie Partners with McLaren F1 to Support Immunology Patients

Oct 21, 2026
AbbVie has announced a multi-year partnership with McLaren Racing, becoming the official pharmaceutical partner of the McLaren Mastercard Formula 1 Team. The collaboration will support…
Read More...

Merck KGaA to Acquire Silence Therapeutics for $1.3 Billion

Oct 20, 2026
Merck KGaA, Darmstadt, Germany, has agreed to acquire Silence Therapeutics, a UK-based biotechnology company, in an all-cash deal valued at approximately $1.3 billion. The acquisition…
Read More...

Lilly’s Omvoh Meets Phase 3 Goal in Pediatric Ulcerative Colitis

Oct 20, 2026
Eli Lilly and Company has announced positive Phase 3 clinical trial results for Omvoh (mirikizumab-mrkz) in children and adolescents with moderately to severely active ulcerative…
Read More...

EyePoint’s DURAVYU Fails Main Endpoint in Phase 3 Wet AMD Trial

Oct 20, 2026
EyePoint, Inc. (NASDAQ: EYPT) has announced topline results from its LUCIA Phase 3 clinical trial evaluating DURAVYU (vorolanib intravitreal insert) as a treatment for wet age-related…
Read More...
Previous 1 … 5 6 7 8 9 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.